A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
Condition: Refractory Solid Tumors Interventions: Drug: Eribulin; Drug: Irinotecan; Drug: Temozolomide Sponsor: M.D. Anderson Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials